Patient & Survivor Care
Feature
Affiliate cancer centers: What’s in a name?
Conference Coverage
Risk model could help predict VTE in acute leukemia
AMSTERDAM – VTE risk modeling is available for patients with solid tumors, but a similar prognostic tool for leukemia patients has been missing....
Conference Coverage
Cell count ratios appear to predict thromboembolism in lymphoma
AMSTERDAM – The findings mean clinicians can look to complete blood count for answers on thromboembolism risk.
From the Journals
CVD risk upped in postmenopausal breast cancer survivors
Overall, breast cancer patients had significantly higher HSP60 levels and lower HSP70 levels than those of their cancer-free peers.
From the Journals
Immunotherapy-treated NSCLC: Adverse impact of steroids driven by palliative indications
A new analysis suggests use of steroids for cancer-related palliation in patients with poor prognosis largely explains their association with...
Conference Coverage
Checkpoint inhibitor–induced rheumatic complications have unique features
MADRID – The phenotypic musculoskeletal complications of checkpoint inhibitors do not resemble other joint pathology.
Conference Coverage
Pregnancy deemed safe in BRCA-mutated breast cancer survivors
Pregnancy did not affect disease-free or overall survival, and complications were similar to the general population.
From the Journals
Rituximab serious infection risk predicted by immunoglobulin levels
Retrospective study findings suggest measuring immunoglobulin levels at baseline and before each rituximab cycle to identify patients at risk of...
Conference Coverage
Olanzapine improves upon standard antiemetic therapy
CHICAGO – Complete response rates were higher among patients who received olanzapine plus standard therapy.
News
The costs of surviving cancer
Annual out-of-pocket spending is 60% higher for survivors, the CDC reported.
Conference Coverage
MADIT-CHIC: CRT aids patients with chemotherapy-induced cardiomyopathy